Akero Therapeutics Inc. (AKRO)

NASDAQ: AKRO · Real-Time Price · USD

45.42

-0.19 (-0.42%)

At close: May 01, 2025, 3:59 PM

43.79

-3.60%

Pre-market: May 02, 2025, 04:01 AM EDT

Akero Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Net Income	-252.06M	-151.76M	-112.03M	-100.78M	-79.21M	-43.76M	-81.71M	-4.56M
Depreciation & Amortization	-13.1M	29K	43K	41K	17K	-104K	n/a	n/a
Stock-Based Compensation	29.7M	21.5M	23.24M	10.05M	6.02M	1.77M	121K	n/a
Other Working Capital	990K	-6.03M	-5.43M	6.45M	-396K	6.89M	-252K	122K
Other Non-Cash Items	2.36M	-8.46M	689K	203K	196K	-104K	75.91M	-60K
Deferred Income Tax	n/a	n/a	n/a	1.07M	83K	104K	n/a	n/a
Change in Working Capital	3M	-6.67M	-4.46M	9.73M	2.08M	6.46M	1.06M	182K
Operating Cash Flow	-230.11M	-145.37M	-92.52M	-79.68M	-70.8M	-35.63M	-4.63M	-4.38M
Capital Expenditures	n/a	n/a	n/a	n/a	-148K	n/a	-5M	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	9.61K	n/a	n/a	n/a
Purchase of Investments	-516.04M	-433.12M	-101.45M	-43.56M	-115.04M	-71.51M	n/a	n/a
Sales Maturities Of Investments	407.33M	209.5M	37.62M	85.84M	105.42M	n/a	n/a	n/a
Other Investing Acitivies	-999K	n/a	-63.83K	42.28K	-9.61K	-71.51K	-5K	n/a
Investing Cash Flow	-109.71M	-223.62M	-63.83M	42.28M	-9.76M	-71.51M	-5M	n/a
Debt Repayment	10M	15M	10M	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	464K	n/a	n/a	373K	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	12.77M	2.89M	4.43M	602K	553K	536K	-493K	5M
Financial Cash Flow	445.85M	353.32M	255.63M	602K	203.11M	95.99M	85.01M	5M
Net Cash Flow	106.03M	-15.67M	99.29M	-36.8M	122.54M	-11.15M	75.38M	618K
Free Cash Flow	-230.11M	-145.37M	-92.52M	-79.68M	-70.95M	-35.63M	-9.63M	-4.38M